Dual HPLC-TLC Platform for Enhanced Quality Control of Alpha-Emitting Radiotherapeutics

Principal Investigator: 

James Kelly, Assistant Professor of Radiopharmaceutical Sciences in Radiology

Background & Unmet Need

  • Radiopharmaceuticals using alpha-emitting isotopes like Ac-225 are emerging as powerful therapeutic tools for treating cancer
  • Current quality control methods using radioHPLC or radioTLC alone cannot accurately assess the purity of complex alpha-emitting compounds
  • Rapid, accurate purity verification is critical for patient safety and regulatory compliance in radiopharmaceutical production
  • Manual handling of radioactive samples increases personnel exposure risks
  • Unmet Need: A standardized method of accurate and rapid quality control analysis of complex radiopharmaceuticals that does not compromise analytical precision and minimizes radiation exposure

Technology Overview

  • The Technology: An integrated HPLC-radioTLC analysis platform for precise radiopharmaceutical quality control
  • The platform features a chemically resistant moving stage with protective cover, compatible with multiple radioTLC scanner models
  • The system uses disposable inserts with absorption-lined wells to prevent cross-contamination
  • PoC Data: A working prototype has been validated across multiple radionuclides (225Ac and 134Ce) and diverse radiopharmaceutical types including small molecules, peptides, antibodies, and nanoparticles.
  • The platform demonstrates rapid analysis times (~30 minutes) while maintaining robust analytical integrity

Technology Applications

  • Quality control analysis in GMP radiopharmaceutical manufacturing
  • Clinical radiopharmacy operations requiring standardized QC procedures
  • Analysis of novel radiotherapeutics in research settings

Technology Advantages

  • Enables precise identification of radiolabeled compounds and their impurities
  • Reduces operator radiation exposure through improved handling design
  • Compatible with existing radioTLC equipment through versatile stage design
  • Accommodates both manual and automated fraction collection methods
Prototype of the integrated HPLCradioTLC platform showing the 3D-printed customizable moving stage with disposable insert installed in a commercial radioTLC scanner.

Figure: Prototype of the integrated HPLCradioTLC platform showing the 3D-printed customizable moving stage with disposable insert installed in a commercial radioTLC scanner.



Intellectual Property

Patents

  • Provisional Application Filed

Cornell Reference

  • 11437

Contact Information

Donna Rounds, Ph.D

For additional information please contact

Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 962-7044
Email: djr296@cornell.edu